Pages that link to "Q37730584"
Jump to navigation
Jump to search
The following pages link to Genital chlamydial infections: epidemiology and reproductive sequelae (Q37730584):
Displaying 50 items.
- Antibiotics for treating genital chlamydia trachomatis infection in men and non-pregnant women (Q24202140) (← links)
- Persistent Chlamydiae and chronic arthritis (Q24792605) (← links)
- Innate immune defences in the human endometrium (Q24801159) (← links)
- Developing a realistic sexual network model of chlamydia transmission in Britain (Q25257521) (← links)
- Target cell limitation constrains chlamydial load in persistent infections: results from mathematical modelling applied to mouse genital tract infection data (Q26851860) (← links)
- Molecular epidemiology and genotyping of Chlamydia trachomatis infection in a cohort of young asymptomatic sexually active women (18-25 years) in Milan, Italy (Q28079643) (← links)
- Differential expression of the natural antimicrobials, beta-defensins 3 and 4, in human endometrium (Q28191288) (← links)
- Translation inhibition of the developmental cycle protein HctA by the small RNA IhtA is conserved across Chlamydia (Q28277185) (← links)
- Sexually transmitted diseases and infertility. (Q30239986) (← links)
- Young pregnant women's views on the acceptability of screening for chlamydia as part of routine antenatal care (Q30496434) (← links)
- C. trachomatis and N. gonorrhoeae surveillance in New Zealand: comparison of laboratory and clinic data (Q30659505) (← links)
- Establishment of a particle-counting method for purified elementary bodies of chlamydiae and evaluation of sensitivities of the IDEIA Chlamydia kit and DNA probe by using the purified elementary bodies (Q31006683) (← links)
- Incentive payments to general practitioners aimed at increasing opportunistic testing of young women for chlamydia: a pilot cluster randomised controlled trial (Q33531560) (← links)
- Sexuality and health: the hidden costs of screening for Chlamydia trachomatis (Q33548198) (← links)
- Azithromycin. A pharmacoeconomic review of its use as a single-dose regimen in the treatment of uncomplicated urogenital Chlamydia trachomatis infections in women (Q33579236) (← links)
- Ability of new APTIMA CT and APTIMA GC assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in male urine and urethral swabs (Q33592330) (← links)
- Heat shock protein expression and immunity in chlamydial infections (Q33609636) (← links)
- Estimating age-dependent per-encounter chlamydia trachomatis acquisition risk via a Markov-based state-transition model (Q33617158) (← links)
- Comparison of performances of two commercially available tests, a PCR assay and a ligase chain reaction test, in detection of urogenital Chlamydia trachomatis infection. (Q33668453) (← links)
- Plaque formation by and plaque cloning of Chlamydia trachomatis biovar trachoma (Q33679270) (← links)
- Use of laboratory testing for genital chlamydial infection in Norway (Q33691251) (← links)
- Multinucleation during C. trachomatis infections is caused by the contribution of two effector pathways (Q33793765) (← links)
- Assessing the presence of Chlamydia trachomatis genome in pregnant women with spontaneous abortion using polymerase chain reaction method in Yasuj: First report from Southwest of Iran (Q33796237) (← links)
- Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis (Q33801635) (← links)
- Evaluation of a high resolution genotyping method for Chlamydia trachomatis using routine clinical samples (Q33828440) (← links)
- Development and evaluation of an ompA quantitative real-time PCR assay for Chlamydia trachomatis serovar determination (Q33909425) (← links)
- Transmission of Chlamydia trachomatis through sexual partnerships: a comparison between three individual-based models and empirical data (Q33926596) (← links)
- Pathogenesis of pelvic inflammatory disease (Q33934169) (← links)
- Genital chlamydial infection among women in Nicaragua: validity of direct fluorescent antibody testing, prevalence, risk factors and clinical manifestations (Q33935904) (← links)
- PCR for detection of Chlamydia trachomatis in endocervical, urethral, rectal, and pharyngeal swab samples obtained from patients attending an STD clinic (Q33937033) (← links)
- High-resolution genotyping of Chlamydia trachomatis from recurrent urogenital infections (Q33968936) (← links)
- Characterization of Chlamydia trachomatis omp1 genotypes among sexually transmitted disease patients in Sweden (Q33973925) (← links)
- Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro (Q33980950) (← links)
- Infectivity of Chlamydia trachomatis serovar LGV but not E is dependent on host cell heparan sulfate (Q34006008) (← links)
- Chlamydia trachomatis infection: incidence, health costs and prospects for vaccine development (Q34038523) (← links)
- General practice update: chlamydia infection in women. (Q34054342) (← links)
- A Stochastic Model for AssessingChlamydia TrachomatisTransmission Risk by Using Longitudinal Observational Data (Q34055102) (← links)
- Semiparametric Frailty Models for Clustered Failure Time Data (Q34070916) (← links)
- Prevalence of Genital Chlamydia and Gonococcal Infections in at Risk Women in the Kumasi Metropolis, Ghana (Q34206499) (← links)
- The prevalence of Chlamydia trachomatis infection in Australia: a systematic review and meta-analysis (Q34268058) (← links)
- Time from first intercourse to first sexually transmitted infection diagnosis among adolescent women (Q34479432) (← links)
- Infertility following pelvic inflammatory disease (Q34503870) (← links)
- Individual and population level effects of partner notification for Chlamydia trachomatis (Q34516651) (← links)
- Tubal pelvic damage: prediction and prognosis (Q34565861) (← links)
- Sexually transmitted infections based on the syndromic approach in Gondar town, northwest Ethiopia: a retrospective study (Q34588704) (← links)
- Specimen processing and concentration of Chlamydia trachomatis added can influence false-negative rates in the LCx assay but not in the APTIMA Combo 2 assay when testing for inhibitors (Q34749921) (← links)
- Characterization of Chlamydia trachomatis omp1 genotypes detected in eye swab samples from remote Australian communities (Q34783035) (← links)
- Prevention of pelvic inflammatory disease by the control of C. trachomatis infection (Q34971250) (← links)
- Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies (Q35021415) (← links)
- First Report of Performance of the Versant CT/GC DNA 1.0 Assay (kPCR) for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae (Q35067145) (← links)